日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Correction: In vitro drug testing using patient-derived ovarian cancer organoids

更正：利用患者来源的卵巢癌类器官进行体外药物测试

期刊:Journal of Ovarian Research
影响因子:4.2
doi:10.1186/s13048-024-01559-1
Chen, Lin-Yu; Chou, Yu-Ting; Liew, Phui-Ly; Chu, Ling-Hui; Wen, Kuo-Chang; Lin, Shiou-Fu; Weng, Yu-Chun; Wang, Hui-Chen; Su, Po-Hsuan; Lai, Hung-Cheng
3D/类器官
肿瘤
肿瘤免疫
卵巢癌
发表日期：2024
文献求助 收藏

BHLHE22 Expression Is Associated with a Proinflammatory Immune Microenvironment and Confers a Favorable Prognosis in Endometrial Cancer.

BHLHE22 表达与促炎免疫微环境相关，并预示着子宫内膜癌的良好预后

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms23137158
Darmawi, Chen Lin-Yu, Su Po-Hsuan, Liew Phui-Ly, Wang Hui-Chen, Weng Yu-Chun, Huang Rui-Lan, Lai Hung-Cheng
肿瘤
子宫内膜癌
肿瘤免疫
发表日期：2022
文献求助 收藏

Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report

帕博利珠单抗联合贝伐珠单抗治疗后，伴有ARID1A突变的重度治疗卵巢透明细胞癌完全缓解：病例报告

期刊:Journal of Ovarian Research
影响因子:4.2
doi:10.1186/s13048-020-00751-3
Lin, Yu-Chien; Wen, Kuo-Chang; Sung, Pi-Lin; Chou, Yu-Ting; Liew, Phui-Ly; Chen, Lin-Yu; Huang, Rui-Lan; Lai, Hung-Cheng; Chang, Lu-Te
细胞生物学
肿瘤
肿瘤免疫
ID1
发表日期：2020
文献求助 收藏

Clinicopathologic and Prognostic Significance of Thymopoietin-α Overexpression in Gastric Cancer

胸腺生成素-α过表达在胃癌中的临床病理及预后意义

期刊:Journal of Cancer
影响因子:3.2
doi:10.7150/jca.30738
Sun, Ding-Ping; Liew, Phui-Ly; Lin, Chih-Chan; Hung, Shih-Ting; Chen, Tai-Chi; Fang, Chia-Lang; Lin, Kai-Yuan
胃癌
肿瘤
肿瘤免疫
发表日期：2019
文献求助 收藏